These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8483545)

  • 21. [Cost-effectiveness of prophylaxis and treatment of influenza].
    Rychlik R; Heinen-Kammerer T; Rusche H; Piercy J; Scuffham P; Zöllner Y
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2267-70. PubMed ID: 14574642
    [No Abstract]   [Full Text] [Related]  

  • 22. Influenza vaccination: cost-effective health care for the older adult?
    Hampson AW; Irving LB
    J Qual Clin Pract; 1997 Mar; 17(1):3-11. PubMed ID: 9107599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maritime health: a case for preventing influenza on the high seas.
    Ruben FL; Ehreth J
    Int Marit Health; 2002; 53(1-4):36-42. PubMed ID: 12608587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Needling the flu. New drugs give relief, but the shot is still tops.
    Fischer JS
    US News World Rep; 1999 Oct; 127(15):100. PubMed ID: 10623289
    [No Abstract]   [Full Text] [Related]  

  • 25. Investments in alcohol treatment can boost employers' bottom lines.
    Raskin E; Williams L
    Issue Brief (George Wash Univ Med Cent Ensuring Solut Alcohol Probl); 2003 Jun; (5):1-2. PubMed ID: 12852423
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cost-effectiveness of influenza vaccination The Netherlands].
    Reinders A; Postma MJ; Govaert TM; Sprenger MJ
    Ned Tijdschr Geneeskd; 1997 Jan; 141(2):93-7. PubMed ID: 9036354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A worksite influenza immunization program. Impact on lost work days, health care utilization, and health care spending.
    Dille JH
    AAOHN J; 1999 Jul; 47(7):301-9. PubMed ID: 10661043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of influenza vaccination for people aged 65 and over in Japan.
    Hoshi SL; Kondo M; Honda Y; Okubo I
    Vaccine; 2007 Aug; 25(35):6511-21. PubMed ID: 17681651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.
    Navas E; Salleras L; Domínguez A; Ibáñez D; Prat A; Sentís J; Garrido P
    Vaccine; 2007 Apr; 25(16):3233-9. PubMed ID: 17324489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS is your business.
    Rosen S; Simon J; Vincent JR; MacLeod W; Fox M; Thea DM
    Harv Bus Rev; 2003 Feb; 81(2):80-7, 125. PubMed ID: 12577655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cost-benefit analysis of practical occupational medicine service].
    Kentner M
    Gesundheitswesen; 1996 Feb; 58(2):102-5. PubMed ID: 8881081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. When doses disappear. Flu shot shortage sheds light on drug supply chain.
    Becker C
    Mod Healthc; 2004 Oct; 34(42):16. PubMed ID: 15552188
    [No Abstract]   [Full Text] [Related]  

  • 33. Health economic research on vaccinations and immunisation practices--an introductory primer.
    Szucs TD
    Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of influenza vaccination timing.
    Yoo BK; Frick K
    Health Econ; 2005 Aug; 14(8):777-91. PubMed ID: 15700301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing medical service utilization by encouraging vaccines: randomized controlled trial.
    Berg GD; Thomas E; Silverstein S; Neel CL; Mireles M
    Am J Prev Med; 2004 Nov; 27(4):284-8. PubMed ID: 15488357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weighing the costs and benefits of worksite health promotion.
    Grana J
    Corp Comment; 1985 Nov; 1(5):18-29. PubMed ID: 10311320
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cost-effectiveness of influenza vaccination in The Netherlands].
    Smit EM
    Ned Tijdschr Geneeskd; 1997 Apr; 141(16):793-4. PubMed ID: 9213803
    [No Abstract]   [Full Text] [Related]  

  • 38. The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over.
    Kelly H; Attia J; Andrews R; Heller RF
    Vaccine; 2004 Jun; 22(17-18):2192-8. PubMed ID: 15149776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cost-benefit analysis--occupational health and safety].
    Rydlewska-Liszkowska I
    Med Pr; 1998; 49(2):201-7. PubMed ID: 9695068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Could a federal program to promote influenza vaccination among elders be cost-effective?
    Patel MS; Davis MM
    Prev Med; 2006 Mar; 42(3):240-6. PubMed ID: 16480761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.